Can the xFakeSci tool identify fake AI-generated content?

Researchers assess the performance of xFakeSci in differentiating authentic scientific content from ChatGPT-generated content.

With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment

CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701

June 1, 2024

Novo Nordisk sues unauthorized semaglutide compounders, tempers expectations for Wegovy’s global rollout

Novo Nordisk is striking back against illegal semaglutide compounders, filing an initial five lawsuits and preparing more in the coming days and weeks. The first

June 21, 2023

ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.